EP1109568A4 - An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factor - Google Patents
An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factorInfo
- Publication number
- EP1109568A4 EP1109568A4 EP99968629A EP99968629A EP1109568A4 EP 1109568 A4 EP1109568 A4 EP 1109568A4 EP 99968629 A EP99968629 A EP 99968629A EP 99968629 A EP99968629 A EP 99968629A EP 1109568 A4 EP1109568 A4 EP 1109568A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- reading frame
- open reading
- stimulating factor
- macrophage colony
- antigenic peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 title 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 title 1
- 108700026244 Open Reading Frames Proteins 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/243—Colony Stimulating Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9907798P | 1998-09-04 | 1998-09-04 | |
US99077P | 1998-09-04 | ||
PCT/US1999/020344 WO2000013699A1 (en) | 1998-09-04 | 1999-09-03 | An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factor |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1109568A1 EP1109568A1 (en) | 2001-06-27 |
EP1109568A4 true EP1109568A4 (en) | 2002-05-08 |
Family
ID=22272533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99968629A Withdrawn EP1109568A4 (en) | 1998-09-04 | 1999-09-03 | An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factor |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1109568A4 (en) |
AU (1) | AU6027399A (en) |
WO (1) | WO2000013699A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1511040A (en) * | 2001-05-25 | 2004-07-07 | ����˹���ѷ��ѧ | Alternative splice forms of proteins as basis for multiple therapeutic modalities |
EP2463299A3 (en) * | 2003-03-05 | 2012-10-17 | Dendreon Corporation | Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
DE102018107224A1 (en) | 2018-02-21 | 2019-08-22 | Immatics Biotechnologies Gmbh | Peptides and combinations of peptides of non-canonical origin for use in immunotherapy against various cancers |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997029195A2 (en) * | 1996-02-09 | 1997-08-14 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
DK54589A (en) * | 1988-02-08 | 1989-08-09 | Otsuka Pharma Co Ltd | HUMAN COLONIST MULATING FACTORS |
JPH03504438A (en) * | 1988-03-30 | 1991-10-03 | アーチ デベロプメント コーポレイション | DNA-binding proteins including androgen receptors |
-
1999
- 1999-09-03 EP EP99968629A patent/EP1109568A4/en not_active Withdrawn
- 1999-09-03 WO PCT/US1999/020344 patent/WO2000013699A1/en not_active Application Discontinuation
- 1999-09-03 AU AU60273/99A patent/AU6027399A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997029195A2 (en) * | 1996-02-09 | 1997-08-14 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
Non-Patent Citations (4)
Title |
---|
MAYRAND S ET AL: "Non-traditionally derived CTL epitopes: exceptions that prove the rules?", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 19, no. 12, December 1998 (1998-12-01), pages 551 - 556, XP004149703, ISSN: 0167-5699 * |
RONG-FU WANG ET AL: "UTILIZATION OF AN ALTERNATIVE OPEN READING FRAME OF A NORMAL GENE IN GENERATING A NOVEL HUMAN CANCER ANTIGEN", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 183, no. 3, 1 March 1996 (1996-03-01), pages 1131 - 1140, XP000674490, ISSN: 0022-1007 * |
See also references of WO0013699A1 * |
WANG R-F ET AL: "HUMAN TUMOR ANTIGENS RECOGNIZED BY T LYMPHOCICYTES: IMPLICATIONS FOR CANCER THERAPY", JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL, US, vol. 60, no. 3, 1 September 1996 (1996-09-01), pages 296 - 309, XP000674591, ISSN: 0741-5400 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000013699A1 (en) | 2000-03-16 |
EP1109568A1 (en) | 2001-06-27 |
AU6027399A (en) | 2000-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0921687A4 (en) | Moving picture encoder and moving picture decoder | |
EP1061749A4 (en) | Moving picture coder and moving picture decoder | |
EP1109568A4 (en) | An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factor | |
CA90197S (en) | Chair cover | |
AU3813497A (en) | Novel human macrophage antigen | |
AU5926296A (en) | Human cis protein | |
EP1077258A4 (en) | Human hrpi | |
IL139595A0 (en) | Human protein c polypeptide | |
KR970048886U (en) | Sliding chair frame | |
TW373468U (en) | Improved structure for the frame of beauty chair | |
TW398230U (en) | Improved structure of mattress | |
AU139412S (en) | Chair lounger | |
CA83418S (en) | Mattress | |
TW364342U (en) | Structure of armchair | |
TW432991U (en) | Improved structure of healthful chair | |
IL142919A0 (en) | Human secretory protein-61 | |
TW315705U (en) | Improved mattress structure | |
AU138840S (en) | Bedframe | |
PL104328U1 (en) | Corner couch | |
GB9612254D0 (en) | Convalescent chair | |
PL106627U1 (en) | Armchair frame | |
TW298785U (en) | Modified structure of chair frame | |
TW302059U (en) | Improved structure of bed frame | |
CA85458S (en) | Mattress topper | |
CA84513S (en) | Bed frame |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010205 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020327 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 38/00 A, 7A 61K 38/19 B, 7A 61K 39/00 B, 7G 01N 33/567 B, 7C 07K 14/00 B, 7C 07K 16/24 B, 7C 07K 14/53 B, 7G 01N 33/50 B |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060119 |